People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Biotechnology, Other Technology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ocugen, Inc. | — | Biotechnology | Series B | $145.6M | $566.9M | 2011 |
| Rvue Holdings, Inc. | — | Other Technology | Seed | $10.6M | $9.2M | 2010 |
| NanoHive Medical LLC | — | Healthtech | Seed | $7.5M | $33.1M | 2022 |
| Endosphere, Inc. | — | Biotechnology | Seed | $6.5M | $88.8M | 2015 |
| Optech4D, Inc. | — | Other Technology | Seed | $3.1M | $61.3M | 2016 |
| Shelfmark, Inc. | — | Other Technology | Seed | $1.3M | $9.9M | 2023 |
Patrick O'Donnell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick O'Donnell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Johnson | 1 | 25 |
| Garheng Kong | 1 | 16 |
| Michael Lewis | 1 | 12 |
| James Taylor | 1 | 12 |
| Kevin Rakin | 1 | 7 |
| Adam Gridley | 1 | 4 |
| Richard Sullivan | 1 | 4 |
| Craig Markovitz | 1 | 3 |
| Kevin McArdle | 1 | 3 |
| Thomas Harrison | 1 | 3 |
| Peter Greenleaf | 1 | 3 |
| Jay Wilson | 1 | 3 |
| Charles Kang | 1 | 2 |
| Joshua Baltzell | 1 | 2 |
| Michael Mullarkey | 1 | 2 |
| Martin Coyne | 1 | 2 |
| John Zhang | 1 | 2 |
| Frank Leo | 1 | 2 |
| Manish Potti | 1 | 2 |
| Timothy Helfet | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.